Publications by authors named "Daniel Aletaha"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

521

Total Likes

32

Extended Reach

60,207

Social Features

38
T
The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, an
Micol Romano, Z Serap Arici, David Piskin, Sara Alehashemi, Daniel Aletaha, Karyl Barron, Susanne Benseler, Roberta A Berard, Lori Broderick, Fatma Dedeoglu

Arthritis Rheumatol· July 2022

Videos about Article: user user

2 36

View All Article and Social Media Activity
R
Rheumatoid arthritis before rheumatoid arthritis: What can we learn from clinical trials?
Daniel Aletaha, Daniela Sieghart

Joint Bone Spine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression from seropositive arthralgia to rheumatoid arthritis: One-year predictors from a large cohort in the Reuma-Check program.
Rodrigo Garcia-Salinas, Nataly MeJia-Maggi, Felicia Almada, Gisel Reyes-Jara, Alvaro Ruta, Daniel Aletaha

Semin Arthritis Rheum· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of radiographic spinal changes and their progression in patients with axial spondyloarthritis vs. psoriatic arthritis with inflammatory axial involvement.
Philipp Sewerin, Imke Redeker, Eirini Lavda, Gabriela Supp, Daniela Sieghart, Daniel Aletaha

Arthritis Res Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies: a retrospective observational study.
Kastriot Kastrati, Thomas Karonitsch, Hanien Rajab, Roman Reindl-Schwaighofer, Farsad Eskandary, Daniel Aletaha

Rheumatology (Oxford)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global recruitment patterns and placebo responses in clinical trials of rheumatoid arthritis.
Andreas Kerschbaumer, Marlene Steiner, Pascale Pruckner, Brigitte Wildner, Magdalena Maad, Daniel Aletaha

Ann Rheum Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FAPI PET/CT for tracking disease trajectory in myositis-related interstitial lung disease.
Kastriot Kastrati, Svitlana Pochepnia, Oana C Kulterer, Thomas S Nakuz, Daniel Mrak, Daniel Aletaha

J Autoimmun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody development after three mRNA SARS-CoV-2 vaccinations in patients with systemic autoimmune rheumatic disease with and without treatment: an observational cohort study.
Elisabeth Simader, Felix Kartnig, Selma Tobudic, Daniel Mrak, Thomas Deimel, Daniel Aletaha

BMJ Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a Disease Activity index for PSoriatic Arthritis based on 44 joints (DAPSA44).
Dafne Capelusnik, Clementina Lopez-Medina, Désirée van der Heijde, Daniel Aletaha, Josef Smolen

Ann Rheum Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024.
Kevin L Winthrop, Joan Bathon, Andreas Kerschbaumer, John D Isaacs, Philip Mease, Daniel Aletaha

Ann Rheum Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Passive maternal immunity in children born to women with systemic autoimmune rheumatic disease - A case-control study.
Antonia Mazzucato-Puchner, Helene Ramspeck, Valentin Ritschl, Tanja Stamm, Valerie Kuczwara, Daniel Aletaha

J Autoimmun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collecting patient-reported outcomes via the COTIDIANA smartphone app: a prospective validity study.
Nasim Nakhost Lotfi, Francisco Nunes, Pedro Matias, Tanja A Stamm, Ricardo Graca, Daniel Aletaha

RMD Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Recruiting Patterns and Placebo Response Rates in Clinical Trials of Psoriatic Arthritis and Plaque Psoriasis.
Andreas Kerschbaumer, Marlene Steiner, Suzanne Khalili, Azad Shehab, Alexander Jordanov, Daniel Aletaha

Arthritis Rheumatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases - a systematic literature review informing the 2024 update of an international expert consensus statement.
Victoria Konzett, Josef S Smolen, Peter Nash, Kevin Winthrop, Daniel Aletaha

Ann Rheum Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statement.
Victoria Konzett, Josef S Smolen, Peter Nash, Daniel Aletaha, Kevin Winthrop

Ann Rheum Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update.
Peter Nash, Andreas Kerschbaumer, Victoria Konzett, Daniel Aletaha, Thomas Dörner

Ann Rheum Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibody development is associated with clinical severity of COVID-19: A cohort study.
Marie Brinkmann, Ludwig Traby, Manuel Kussmann, Matthias Weiss-Tessbach, Nina Buchtele, Daniel Aletaha

Clin Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag, Juan Molina-Collada, Ramatoulaye Ndoye, Daniel Aletaha, Johan Askling

Ann Rheum Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to treat undifferentiated arthritis today or tomorrow? A consideration of treatment recommendations in light of current evidence.
Annette H M van der Helm-van Mil, Daniel Aletaha

Ann Rheum Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Uncoupling of Disease Activity from Joint Structural Progression in Patients with Rheumatoid Arthritis Treated with Filgotinib.
Yoshiya Tanaka, Tatsuya Atsumi, Daniel Aletaha, Hendrik Schulze-Koops, Haruhiko Fukada

Rheumatol Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo imaging-based high content phenotyping of patients with rheumatoid arthritis.
Felix Kartnig, Michael Bonelli, Ulrich Goldmann, Noemi Mészáros, Nikolaus Krall, Daniel Aletaha

EBioMedicine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management strategies in rheumatoid arthritis.
Victoria Konzett, Daniel Aletaha

Nat Rev Rheumatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag, Kim Lauper, Juan Molina-Collada, Daniel Aletaha, Johan Askling

Ann Rheum Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity or mannose-binding lectin deficiency : A prospective controlled open-label trial.
Matthias G Vossen, Felix Kartnig, Daniel Mrak, Elisabeth Simader, Karin Stiasny, Daniel Aletaha

Wien Klin Wochenschr· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial.
Johanna Elin Gehin, Rolf Anton Klaasen, Eirik Klami Kristianslund, Ingrid Jyssum, Joseph Sexton, Daniel Aletaha

RMD Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study.
Maya H Buch, Daniel Aletaha, Bernard G Combe, Yoshiya Tanaka, Roberto Caporali

RMD Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis